Product
Help
Pricing
About
Jobs
Log in
Get started
Award
Add to collection
MC_UU_00004/03
Funder:
Medical Research Council
Funded outputs count:
117
Funder award ID:
MC_UU_00004/03
OpenAlex ID:
G553738029
Virological outcomes and genotypic resistance on dolutegravir-based antiretroviral therapy versus standard of care in children and adolescents: a secondary analysis of the ODYSSEY trial
2025
·
Ellen White
, Cissy Kityo
, et al.
·
The Lancet HIV
·
16
Are children and adolescents living with HIV in Europe and South Africa at higher risk of SARS-CoV-2 and poor COVID-19 outcomes?
2025
·
Charlotte Jackson
, Siobhan Crichton
, et al.
·
Epidemiology and Infection
·
1
PDF
Challenges in estimating the counterfactual placebo HIV incidence rate from a registration cohort: The PrEPVacc trial
2024
·
Sheila Kansiime
, Christian Holm Hansen
, et al.
·
Clinical Trials
·
2
Contraceptive use, prevalence and incidence of pregnancy and associated factors among women participating in a vaccine preparedness cohort study in Masaka, Uganda, a retrospective secondary analysis
2024
·
Sylvia Kusemererwa
, Sheila Kansiime
, et al.
·
Reproductive Health
·
3
PDF
Determining Targets for Antiretroviral Drug Concentrations: A Causal Framework Illustrated With Pediatric Efavirenz Data From the CHAPAS ‐3 Trial
2024
·
Michael Schomaker
, Paolo Denti
, et al.
·
Pharmacoepidemiology and Drug Safety
·
3
PDF
Assessing Whether Providing Regular, Free HIV Self-Testing Kits Reduces the Time to HIV Diagnosis: An Internet-Based, Randomized Controlled Trial in Men Who Have Sex With Men
2024
·
David T. Dunn
, Leanne McCabe
, et al.
·
JAIDS Journal of Acquired Immune Deficiency Syndromes
·
1
How can HIV self-testing facilitate increased access to HIV testing among multiply marginalised populations? Perspectives from GBMSM and trans women in England and Wales
2024
·
Isaac Yen-Hao Chu
, Fiona M. Burns
, et al.
·
PLoS ONE
·
5
Optimising Paediatric HIV Treatment: Recent Developments and Future Directions
2024
·
Anne E. M. Kamphuis
, Alasdair Bamford
, et al.
·
Pediatric Drugs
·
14
PDF
Recoverability of causal effects under presence of missing data: a longitudinal case study
2024
·
Anastasiia Holovchak
, Helen McIlleron
, et al.
·
Biostatistics
·
9
PDF
What is the carbon footprint of academic clinical trials? A study of hotspots in 10 trials
2024
·
Jessica Griffiths
, Fiona Adshead
, et al.
·
BMJ Open
·
19
PDF
Human immunodeficiency virus prevention and testing strategies among men who have sex with men in the UK: the PANTHEON research programme including the SELPHI RCT
2024
·
Janey Sewell
, T Charles Witzel
, et al.
·
Programme Grants for Applied Research
Footprints of innate immune activity during HIV-1 reservoir cell evolution in early-treated infection
2024
·
Weiwei Sun
, Ce Gao
, et al.
·
The Journal of Experimental Medicine
·
13
PDF
Influence of age and co‐medication on dolutegravir glucuronidation in paediatric patients
2024
·
Tom G. Jacobs
, Hylke Waalewijn
, et al.
·
British Journal of Clinical Pharmacology
·
2
PDF
Cardiovascular disease risk in people of African ancestry with HIV in the United Kingdom
2024
·
Stephanie Ko
, Lourdes Dominguez‐Dominguez
, et al.
·
HIV Medicine
·
2
PDF
Biomarkers of mortality in adults and adolescents with advanced HIV in sub-Saharan Africa
2024
·
Victor Riitho
, Roisin Connon
, et al.
·
Nature Communications
·
14
MAVMET trial: maraviroc and/or metformin for metabolic dysfunction associated fatty liver disease in adults with suppressed HIV
2024
·
Leanne McCabe
, James E. Burns
, et al.
·
AIDS
·
6
Factors associated with engagement in HIV care for young people living with perinatally acquired HIV in England: An exploratory observational cohort study
2024
·
Marthe Le Prevost
, Ali Judd
, et al.
·
PLoS ONE
·
3
D3/Penta 21 clinical trial design: A randomised non-inferiority trial with nested drug licensing substudy to assess dolutegravir and lamivudine fixed dose formulations for the maintenance of virological suppression in children with HIV-1 infection, aged 2 to 15 years
2024
·
Anna Turkova
, Man K. Chan
, et al.
·
Contemporary Clinical Trials
·
9
Type 1 Human Immunodeficiency Virus (HIV-1) Incidence, Adherence, and Drug Resistance in Individuals Taking Daily Emtricitabine/Tenofovir Disoproxil Fumarate for HIV-1 Pre-exposure Prophylaxis: Pooled Analysis From 72 Global Studies
2024
·
Raphael J Landovitz
, Li Tao
, et al.
·
Clinical Infectious Diseases
·
22
PDF
Voluntariness of consent in paediatric HIV clinical trials: a mixed-methods, cross-sectional study of participants in the CHAPAS-4 and ODYSSEY trials in Uganda
2024
·
Shafic Makumbi
, Francis Bajunirwe
, et al.
·
BMJ Open
PDF
Effectiveness and Safety of Direct-acting Antivirals for Treatment of Adolescents With HCV/HIV Coinfection: Real-world Data From Europe
2024
·
Farihah Malik
, Siobhan Crichton
, et al.
·
The Pediatric Infectious Disease Journal
·
1
Beliefs about antiretroviral therapy and their association with adherence in young people living with perinatal HIV in England: a cross-sectional analysis
2024
·
Iona White
, Ali Judd
, et al.
·
AIDS Care
·
2
Disseminating the research findings from the adolescents and adults living with Perinatal HIV (AALPHI) study: an approach from young people living with HIV
2024
·
Kate Sturgeon
, Ali Judd
, et al.
·
Research Involvement and Engagement
·
4
PDF
“They Have to Make an Effort Too”: What Decliners Can Teach Us About HIV Cure/Remission-Related Clinical Trials? Results from a French Qualitative Study
2024
·
Sarah Lefebvre
, Jean-Daniel Lelièvre
, et al.
·
AIDS Research and Human Retroviruses
·
4
“Getting pregnant during COVID-19 was a big risk because getting help from the clinic was not easy”: COVID-19 experiences of women and healthcare providers in Harare, Zimbabwe
2024
·
Zivai Mupambireyi
, Frances M. Cowan
, et al.
·
PLOS Global Public Health
·
4
PDF
Show more works
View as search
Year
Topic
